Atopic Dermatitis in COVID-19 Pandemic: A Systematic Review

Rika Desviorita

Abstract: Background: Atopic dermatitis is characterized by immune dysregulation, which may predispose toward worse COVID-19 outcomes but there are still conflicting results in the literature regarding the frequency of allergic diseases in COVID-19 patients. Purpose: To analyze the effect of having an atopic dermatitis on COVID-19 disease severity. Method: This journal analyzes 18 journals that explain about atopic dermatitis in COVID-19 pandemic. Conclusion: No significant association of AD with COVID-19 severity.

Keywords: Atopic dermatitis, COVID-19, disease severity

How to Cite?: Rika Desviorita, "Atopic Dermatitis in COVID-19 Pandemic: A Systematic Review", Volume 11 Issue 4, April 2022, International Journal of Science and Research (IJSR), Pages: 42-47, https://www.ijsr.net/getabstract.php?paperid=SR22330083648, DOI: https://dx.doi.org/10.21275/SR22330083648